Empagliflozin and Protecting Microvascular Support of Heart Mechanics: SGLT2 Inhibition or More?
JACC Basic Transl Sci
.
2019 Sep 23;4(5):592-595.
doi: 10.1016/j.jacbts.2019.08.003.
eCollection 2019 Sep.
Authors
Chris Sorel Mantsounga
1
2
,
Alan R Morrison
1
2
Affiliations
1
Providence VA Medical Center, Providence, Rhode Island.
2
Section of Cardiovascular Medicine, Department of Internal Medicine, Alpert Medical School at Brown University, Providence, Rhode Island.
PMID:
31769446
PMCID:
PMC6872768
DOI:
10.1016/j.jacbts.2019.08.003
No abstract available
Keywords:
cardiomyocyte; empagliflozin; endothelial cell; heart failure; microvasculature.
Publication types
Editorial
Comment
Grants and funding
P20 GM103652/GM/NIGMS NIH HHS/United States
R01 HL139795/HL/NHLBI NIH HHS/United States
UL1 TR001863/TR/NCATS NIH HHS/United States